Human genetics is the scientific study of inherited human variation. Understanding genetic factors and genetic disorders is important in learning more about promoting health and preventing disease. Some genetic changes have been associated with an increased risk of having a child with a birth defect or developmental disability or developing diseases such as cancer or heart disease. 根据Gen Consulting公司最新分析, the global human genetics market is poised to grow by USD 52 亿期间 2022-2028, 复合年增长率为 15.3% 在预测期内.

该行业报告提供了全球市场的市场预测, 接下来是对应用的详细分析, test method, 和地区. The global market data on human genetics can be segmented by application: diagnostic & treatment, preventive medicine, 其他的. The diagnostic & treatment segment is estimated to account for the largest share of the global human genetics market. Human genetics market is further segmented by test method: carrier testing, karyotyping, next-generation sequencing (NGS), noninvasive prenatal testing (NIPT), pharmacogenomic testing, SEPT9 biomarker testing, thrombophilia testing, 其他的. 根据地区, the human genetics market is segmented into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

The global human genetics market is highly competitive. Key companies profiled in the report include Atrys Health S.A., Bode Cellmark Forensics Inc., Elabscience Biotechnology Inc., EUROFINS MEGALAB S.A., FULLGENOMICS S.L., GENinCode Plc, Genologica, LABORATORIO ECHEVARNE S.A., Myriad Genetics Inc., NIMGENETICS GENOMICA Y MEDICINA S.L., Sistemas Genomicos S.L., SYNLAB International GmbH.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Human Genetics Market
– Identify segments/areas to invest in over the forecast period in the Global Human Genetics Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.